Thursday, February 2, 2017

GM-CSF

Generic name: Sargramostim
Trade name: LeukineTM
Other name: Granulocyte-Macrophage Colony Stimulating Factor

Source: http://chemocare.com/chemotherapy/drug-info/gm-csf.aspx
Chemocare.com uses generic names in all descriptions of drugs. Leukine is the trade name for Sargramostim. GM-CSF and Granulocyte-Macrophage Colony Stimulating Factor are other names for Sargramostim. In some cases, health care professionals may use the trade name Leukine or other names GM-CSF and Granulocyte-Macrophage Colony Stimulating Factor when referring to the generic drug name Sargramostim.
Drug type: GM-CSF is a biologic response modifier. GM-CSF is classified as a colony stimulating factor.  (For more detail, see "How this drug works" section below).
What GM-CSF is used for:
  • Used to accelerate the recovery of white blood cells following chemotherapy.
  • Used following induction chemotherapy in Acute Myelogenous Leukemia (AML).
  • After bone marrow transplantation.
  • Before and/or after peripheral blood stem cell transplantation. 
  • Sargramostim is a support medication.  It does not treat cancer.
Note:  If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.
How GM-CSF is given:
  • As an injection under the skin (subcutaneous, SubQ).
  • As an infusion into the vein (intravenous, IV).
  • How it is given depends on why you are receiving this drug.
  • The amount of sargramostim that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated.  Your doctor will determine your dose and schedule.
Side effects of GM-CSF: 
Important things to remember about the side effects of sargramostim:
  • Most people do not experience all of the side effects listed.
  • Side effects are often predictable in terms of their onset and duration. 
  • Side effects are almost always reversible and will go away after treatment is complete.
  • There are many options to help minimize or prevent side effects.
  • There is no relationship between the presence or severity of side effects and the effectiveness of the medication.
  • Sargramostim is a support medication.  The following list includes side effects attributed to sargramostim. Other side effects experienced were attributed to the chemotherapy and/or the disease.
The following side effects are common (occurring in greater than 30%) for patients taking GM-CSF:
  • With the first dose of sargramostim a person may experience low blood pressure, fast heart rate, flushing, lightheadedness or feeling faint.  This is referred to as "first-dose effect," and tends not to happen with future doses.
  • Diarrhea.
  • Local reactions at the injection site. (swelling, redness and tenderness)  
  • Weakness and fatigue
These side effects are less common side effects (occurring in about 10-29%) of patients receiving GM-CSF:
  • Mild flu-like syndrome (fever, headache, generalized aches and pains, weakness and fatigue).
  • Swelling in your hands and feet.
A rare (< 1%) but significant side effect is problem with blood clots.  Blood clots rarely can lead to pulmonary embolus or stroke - potentially life-threatening conditions.
Another serious, but very uncommon side effect of sargramostim is "capillary leak syndrome" or "vascular leak syndrome."  Capillary leak syndrome is a potentially serious disease in which fluids within the vascular system (veins and capillaries) leaks into the tissue outside the bloodstream.  This results in low blood pressure and poor blood flow to the internal organs.  Capillary leak syndrome is characterized by the presence of 2 or more of the following 3 symptoms; low blood pressure, swelling, and low levels of protein in the blood.  Your doctor will monitor these things carefully while you are taking sargramostim.   You should notify your doctor immediately if you notice dizziness (especially when changing position), sudden swelling or rapid weight gain, little or no urine output (for 8-12 hours), shortness of breath, difficulty breathing, irregular heart beats, or chest pain.
Not all side effects are listed above. Some that are rare (occurring in less than 10% of patients) are not listed here.  However, you should always inform your health care provider if you experience any unusual symptoms.
When to contact your doctor or health care provider:
Seek emergency help immediately and notify your health care provider, it you experience the following symptoms:
  • Shortness of breath, wheezing, difficulty breathing, closing up of the throat, swelling of facial features, hives (possible allergic reaction).
Contact your health care provider immediately, day or night, if you should experience any of the following symptoms:
  • Fever of 100.4° F (38° C) or higher, chills (possible signs of infection)
  • Dizziness (especially when changing position), sudden swelling or rapid weight gain, little or no urine output (for 8-12 hours), shortness of breath, difficulty breathing, irregular heart beats, or chest pain.
The following symptoms require medical attention, but are not an emergency.  Contact your health care provider within 24 hours of noticing any of the following:
  • Diarrhea (4-6 episodes in a 24-hour period)
  • Extreme fatigue (unable to carry on self-care activities)
  • Swelling, redness and/or pain in one leg or arm and not the other
Always inform your health care provider if you experience any unusual symptoms.
Precautions: 
  • Before starting sargramostim treatment, make sure you tell your doctor about any other medications you are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.
  • Do not receive any kind of immunization or vaccination without your doctor's approval while taking sargramostim.
  • Sargramostim must be given at least 24 hours after the last dose of chemotherapy and 12 hours after radiation therapy.  
  • Inform your health care professional if you are pregnant or may be pregnant prior to starting this treatment.  Pregnancy category C (use in pregnancy only when benefit to the mother outweighs risk to the fetus).
  • For both men and women: Do not conceive a child (get pregnant) while taking sargramostim. Barrier methods of contraception, such as condoms, are recommended. Discuss with your doctor when you may safely become pregnant or conceive a child after therapy.
  • Do not breast feed while taking this medication.
Self-care tips:
  • Injection tips:
    • Allow sargramostim to come to room temperature before injecting. 
    • Rotate injection sites. 
    • Do not rub the skin before or after injections.
    • Apply ice to the site for 1 minute immediately prior to injecting.
    • Inject slowly. 
    • Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise.
  • If you are taking sargramostim for low white blood cells following chemotherapy, you may be at risk of infection so try to avoid crowds or people with colds and those not feeling well, and report fever or any other signs of infection immediately to your health care provider.
  • Wash your hands often.
  • For flu-like symptoms, keep warm with blankets and drink plenty of liquids.
  • Acetaminophen or ibuprophen may help relieve discomfort from fever, headache and/or generalized aches and pains.  However, be sure to talk with your doctor before taking it.
  • Get plenty of rest. 
  • Maintain good nutrition.
  • If you experience symptoms or side effects, be sure to discuss them with your health care team. They can prescribe medications and/or offer other suggestions that are effective in managing such problems.
Monitoring and testing:
You will be checked regularly by your health care professional while you are taking sargramostim, to monitor side effects and check your response to therapy.  Periodic blood work to monitor your complete blood count (CBC) as well as the function of other organs (such as your kidneys and liver) will also be ordered by your doctor.   
How GM-CSF works:
Colony-Stimulating Factors:
In the body's bone marrow (the soft, sponge-like material found inside bones) blood cells are produced.  There are three major types of blood cells; white blood cells, which fight infection; red blood cells, which carry oxygen to and remove waste products from organs and tissues; and platelets, which enable the blood to clot.  Cancer treatments such as chemotherapy and radiation therapy can effect these cells which put a person at risk for developing infections, anemia and bleeding problems.  Colony-stimulating factors are substances that stimulate the production of blood cells and promote their ability to function.   They do not directly affect tumors but through their role in stimulating blood cells they can be helpful as support of the persons immune system during cancer treatment.
Sargramostim is a growth factor that stimulates the production, maturation and activation of three types of white blood cells (WBC): neutrophils, macrophages and dendritic cells.  Each of these three cells has a distinct purpose and function within the immune system.  Neutrophils are the most abundant WBC and are the first to responde to the site of an infection.  Their purpose is to capture and digest foreign invaders such as bacteria.  Macrophages also capture and digest foreign invaders but are longer acting and recognize more invaders than neutrophils.  Dendritic cells make up less than 1% of WBC's but are extremely important.  They continuously scan their environment and alert other cells when they find something foreign such as an infection.
For patients receiving chemotherapy, sargramostim can accelerate the recovery of these white blood cells that can then enhance recovery.  Sargamostim is also used to stimulate the early stem cells prior to harvesting for peripheral stem cell transplant, and stimulate recovery of bone marrow cells after bone marrow trasplantation.
Note:  We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.  

Source: http://chemocare.com/chemotherapy/drug-info/gm-csf.aspx

Human Stem Cells

True or False? One example of Human Stem Cells - Do your own Research


Look Younger, Feel Better and Improve Your Health with
Stem Cell 100® or Stem Cell 100+®

Stem Cell 100® is designed to rejuvenate your body and slow the aging process to help you feel and function more like a young person. This can help you feel better, look younger and improve your health.
Most of the cells in your body lose function with age. Everyone has special cells called adult stem cells which are needed to repair damaged and old tissues, but adult stem cells themselves are also aging.
Until now there was not much you could do about it. Stem Cell 100® rejuvenates adult stem cells and their micro-environments with the proprietary SC100® formula.  Stem Cell 100+® is a more powerful and faster acting version of the same nutraceutical.
Developed by experts in the anti-aging field, patent-pending Stem Cell 100® is the only supplement proven to double maximum lifespan of an animal model. No other product or therapy including caloric restriction even comes close.
Harness the Power of Your Own Stem Cells
Millions of people suffer from chronic conditions of aging and disease. Based on international scientific studies in many academic and industry laboratories, there is new hope that many of the conditions afflicting mankind can some day be cured or greatly improved using stem cell regenerative medicine.
Stem Cell 100® offers a way to receive some of the benefits of stem cell therapy today by improving the effectiveness of your own adult stem cells.
Stem Cell 100® Helps to Support:
  1. Adult stem cell rejuvenation [1-4]
  2. A healthy cardiovascular system [5-8]
  3. Healthy blood glucose levels for those already in the normal range [9-13]
  4. Healthy blood pressure levels for those already in the normal range [14-15]
  5. Healthy cholesterol levels for those already in the normal range [9, 16-17]
  6. Younger looking skin [18-24]
  7. Better learning and focus [25-30]
  8. More endurance with vigorous exercise [31-35]
  9. A healthy immune system [31-32, 36-39]
  10. Healthy breasts, colon, pancreas, and prostate [40-46]
The statements above have not been reviewed by the FDA. Stem Cell 100® is not a preventive or treatment for any disease.
Help Rejuvenate Your Body by Boosting Your Own Stem Cells
As a child, we are protected from the ravages of aging and can rapidly recover from injury or illness because of the ability of the young regenerative stem cells of children have a superior ability to repair and regenerate most damaged tissues.
As we age, our stem cell populations become depleted and/or slowly lose their capacity to repair. Moreover, the micro-environment (i.e. niches) around stem cells becomes less nurturing with age, so cell turnover and repair are further reduced. This natural progression occurs so slowly that we are barely aware of it, but we start to notice the body changes in our 20s, 30s, 40s, and especially after 50 years of age.
Stem Cell 100® helps adults regain their youthful regenerative potential by stabilizing stem cell function.
Stem Cell 100® works differently than other stem cell products on the market
You may have seen a number of products that are advertised as stimulating or enhancing the number of stem cells. Each person only has a limited number of stem cells so using them up faster may not be a good strategy. Stem Cell 100® is about improving the effectiveness and longevity of your stem cells as well as preserving the stem cell micro-environment. That should be the goal of any effective stem cell therapy and is what Stem Cell 100® is designed to do and what other stem cell products cannot do.
Stem Cell 100® Extends Drosophila (Fruit Fly) Lifespan
In extensive laboratory testing Stem Cell 100® greatly extended both the average and maximum lifespan of Drosophila fruit flies. The study (see Charts below) included three cages of Drosophila fruit flies that were treated with Stem Cell 100® (Cages T1 to T3) and three cages which were untreated controls (Cages C1 to C3). Each cage started with 500 fruit flies including 250 males and 250 females.
The experiment showed that median lifespan more than doubled with a 123% increase.
While fruit flies are not people they are more like us than you might think. Drosophila have a heart and circulatory system, and the most common cause of death is heart failure. Like humans and other mammals (e.g. mice), it is difficult to increase their lifespan significantly.
These observed results outperform every lifespan enhancing treatment ever tested – including experiments using genetic modification and dietary restriction.
The longest living fruit fly receiving Stem Cell 100® lived 89 days compared to the longest living untreated control which lived 48 days. It is possible that the single longest living fruit fly lived longer for other reasons such as genetic mutation, however, there were many others that lived almost as long so it was not just an aberation.
The oldest 5% of the treated fruit flies lived 77% longer than the oldest 5% of the control group. It is also important that the study showed an improved ability of the fruit flies to survive stress and illness at all ages not just during old age. Even after the first few days of the study there were already more of the
Stem Cell 100® treated fruit flies alive that survived youth than the control group of untreated fruit flies. For additional information about the study please go to our Longevitypage.
Supplement Facts
Stem Cell 100® and Stem Cell 100+® are Patent-Pending Life Code® Nutraceuticals.
All Life Code® products are nutraceutical grade and provide the best of science along with the balance of nature. Stem Cell 100 is vegetarian.
Serving Size: One type O capsule
Servings Per Container: 60 Capsules
Recommended Use: Typical usage of Stem Cell 100® is two capsules per day, preferably at meal times. While both capsules can be taken at the same time, it is preferable to separate the two capsules by at least 4 hours. Since Stem Cell 100® is a potent formulation, do not take more than three capsules per day. One capsule per day may be sufficient for those below 110 pounds.
Recommended Users: Anyone from ages 22 and up could benefit from Stem Cell 100®or Stem Cell 100+®. Those in their 20s and 30s will like the boost in endurance during sports or exercise, while older users will notice better energy and general health with the potential for some weight loss.
Stem Cell 100® was our first multi-pathway longevity nutraceutical. Stem Cell 100+® is a more advanced, faster acting and powerful version of Stem Cell 100®.

Click label to enlarge

Active Stem Cell 100 Ingredients: There are ten herbal components that make up the patent-pending combination in Stem Cell 100®. The herbal components are highly extracted natural herbs that are standardized for active components that promote adult stem cells and lower inflammation:
1) Polysaccharides, flavonoids, and astragalosides extracted from Astragalus membranaceus, which has many positive effects on stem cells and the cardiovascular and immune systems.
2) Proprietary natural bilberry flavonoids and other compounds from a stabilized nutraceutical grade medicinal Vaccinium extract. Activate metabolic PPARS and helps produce healthy levels of cholesterol and inflammation. Also has anti-fungal and anti-viral activity.
3) Flavonoids and oligo-proanthocyanidins (OPCs) extracted from Pine Bark, which greatly reduce oxidative stress, DNA damage, and inflammation.
4) L-Theanine, which is a natural amino acid from Camellia sinesis that reduces mental stress and inflammation while improving cognition and protecting brain cells from ischemic or toxic injury.
5) Pterocarpus Marsupium, which contains two stable resveratrol analogs which promote stem cells, lower inflammation, and stabilized metabolism.
6) Polygonum Multiflorium stem stem is a popular Chinese herbal tonic that fights premature aging and promotes youthfulness. Polygonum is reported to enhance fertility by improving sperm count in men and egg vitality in women. Polygonum is also widely used in Asia to strengthen muscle and is thus used by many athletes as an essential tonic for providing strength and stamina to the body.
Modern research has supported Polygonum multiflorium stem in that animal studies have proven that it can extend lifespan and improve the quality of life. Polygonum appears to protect the liver and brain against damage, perhaps by improving immune and cardiovascular health. The stem sections of Polygonum multiflorium are also calming to the nervous system and promote sounder sleep. Life Code® uses a proprietary Polygonum multiflorium stem extract.
7) Schisandra Berry is used by many Chinese women to preserve their youthful beauty. For thousands of years, Schisandra has been prized as an antiaging tonic that increases stamina and mental clarity, while fighting stress and fatigue. In Chinese traditional medicine, Schisandra berry has been used for liver disorders and to enhance resistance to infection and promote skin health and better sleep.
Schisandra berry is classified as an adaptogen, which can stimulate the central nervous system, increase brain efficiency, improve reflexes, and enhance endurance. Modern research indicates that Schisandra berry extracts have a protective effect on the liver and promote immunity. A double-blind human trial suggested that Schisandra berry may help patients with viral hepatitis, which is very prevalent in China.
Recent work indicates that the liver is protected by the enhanced production of glutathione peroxidase, which helps detoxify the liver. Life Code® uses a proprietary Schisandra berry extract.
8) Fo-Ti Root (aka He-Shou-Wu) is one of the most widely used Chinese herbal medicines to restore blood, kidney, liver, and cardiovascular health. Fo-Ti is claimed to have powerful rejuvenating effects on the brain, endocrine glands, the immune system, and sexual vigor.
Legend has it that Professor Li Chung Yun took daily doses of Fo-Ti to live to be 256 and is said to have outlived 23 wives and spawned 11 generations of descendents before his death in 1933. While it is unlikely that he really lived to such an old age there is scientific support for Fo-Ti as beneficial for health and longevity.
Like the Indian Keno bark, Fo-ti contains resveratrol analogs and likely acts by various mechanism, which includes liver detoxification and protection of skin from UVB radiation. Life Code® uses a proprietary Fo-Ti root extract.
9) Camellia sinensis has many bioactive polyphenols including the potent epigallocatechin-3-gallate (EGCG). A 2006 Japanese study published in the Journal of the American Medical Association reports that adults aged 40 to 79 years of age who drank an average of 5 or more cups of tea per day had a significantly lower risk of dying from all causes (23% lower for females and 12% lower for males). The study tracked more than 40,000 adults for up to 11 years and found dramatically lower rates of cardiovascular disease and strokes in those drinking 5 or more cups of tea.
Many studies have found that adults drinking 3 or more cups of tea per day have significantly less cancer. Other studies have found that green tea helps protect against age-related cognitive decline, kidney disease, periodontal disease, and type 2 diabetes. Green tea also promotes visceral fat loss and higher endurance levels.
Summarizing all of the thousands of studies on tea and tea polyphenols that have been published, it can be concluded that tea polyphenols preserve health and youth. This conclusion is backed up by gene studies showing that tea polyphenols decrease insulin-like growth factor-1 (IGF-1), which is a highly conserved genetic pathway that has been strongly linked to aging in yeast, worms, mice, and humans. If everyone could drink 4 to 5 cups of green tea each day, they could enjoy these important health benefits, but for most people drinking that much green tea can disturb their sleep patterns.
Life Code® uses a nutraceutical grade green tea extract that has 98% polyphenols and 50% ESCG that provides the polyphenol and ESCG equivalent of 4 to 5 cups of green tea with only 2% of the caffeine. Thus, most or all of the benefits of green tea are provided without concerns about disturbing sleep.
10) Drynaria Rhizome is used extensively in traditional Chinese medicine as an effective herb for healing bones, ligaments, tendons, and lower back problems. Eastern martial art practitioners have used Drynaria for thousands of years to help in recovering from sprains, bruises, and stress fractures.
Drynaria has also helped in many cases of bleeding gums and tinnitus (ringing in the ears). The active components of Drynaria protect bone forming cells by enhancing calcium absorption and other mechanisms. Drynaria is also reported to act as a kidney tonic and to promote hair growth and wound healing. Life Code® uses a proprietary Drynaria rhizome extract.
Safety: The extracts in both versions of Stem Cell 100® are pharmaceutical grade and have been individually tested in both animals and humans without significant safety issues. Those with pre-existing conditions of diabetes or hypertension should coordinate this product with your doctor, as lower blood glucose or reduced blood pressure can result from taking the recommended dose of this product.
Warnings: may lower glucose and/or blood pressure in some individuals. The supplement is not recommended for pregnant, lactating, or hypoglycemic individuals.

Source: http://www.lifecoderx.com/Stem-Cell-100/?gclid=CMjj7d_q59ECFRi4wAodPQcPUQ

L-Carnosine and Autism

L-Carnosine and Autism

2
7655

Improving Language and Behavior in Children Diagnosed with Autistic Spectrum Disorder (ASD)

Jim English
L-Carnosine (Fig. 1) is a naturally occurring amino acid found in high concentrations in muscle, heart and brain tissues. L-Carnosine – not to be confused with the popular supplement, L-carnitine – is a highly effective anti-aging nutrient that possesses powerful antioxidant, free radical scavenging and neurotransmitter properties. Carnosine inhibits the formation of carbonyl groups, thereby reducing the formation of abnormal proteins. L-Carnosine extends maximum cell division capacity, protects against DNA oxidation, blocks glycosylation and reduces Advanced Glycation Endproducts (AGEs), as well as acting as a cell membrane stabilizer and an intracellular buffer (Fig. 2).
L-Carnosine is already a well-established anti-aging nutrient that is used to treat liver disease, cataracts, Alzheimer’s disease, and cancer. L-Carnosine has recently been shown to possess a tremendous potential for improving language and behavior in children diagnosed with Autistic Spectrum Disorders (ASD).

New Research 

Researchers treated 31 autistic children, ranging from 3 to 12 years in age, with either 400 mg of L-Carnosine, twice a day, or a placebo, for 8 weeks. At the end of the study the children treated with L-Carnosine showed significant improvements in behavior, socialization, and communication, as well as increases in language comprehension based on CARS (Childhood Autism Rating Scale), vocabulary tests (E/ROWPVT) and biweekly parent reports. In the conclusion to their report the researchers state, “Oral supplementation with L-Carnosine resulted in demonstrable improvements in autistic behaviors, as well as increases in language comprehension that reached statistical significance.”

Benefits of L-Carnosine in Autism

In the Chez, et al study, the researchers report that L-Carnosine may improve receptive language, auditory processing, socialization, awareness of surroundings, and even help fine motor planning and expressive language when compared to placebo. Responses are usually seen between one to eight weeks after beginning treatment.

Dosage 

Based on his clinical experience in treating autistic spectrum disorders, Dr. Chez recommends 400 mg of carnosine, twice daily, as an effective dose. Carnosine is available in 50 mg capsules (which allows for smaller doses and greater parental control when titrating to evaluate treatment effectiveness) and 500 mg capsules. L-Carnosine can be given with or without food, and since it is tasteless capsules may be opened to mix the white powder with foods and liquids. L-Carnosine is well tolerated by diabetics and can be used with ketogenic and gluten-casein free diets.

Long-Term Use 

Anecdotal evidence suggests that some autistic children regress in some of their language gains when treatment with L-Carnosine was stopped. All children regained function when dosing was restarted.

Safety 

Carnosine is considered an extremely non-toxic and safe substance. As with other antioxidants, carnosine acts synergistically when taken with other antioxidants. (For example, when vitamin E was taken with carnosine, levels of both substances were higher in cardiac muscle than when either was taken alone.)

Side Effects

Chez reports that manic or hyperactive autistic patients may show signs of over stimulation, including increased irritability, hyperactivity, or insomnia, when given higher doses of L-Carnosine. Symptoms usually respond by decreasing either the dose of L-Carnosine or other medications concurrently. No permanent negative physical changes have been noted in over 1,000 children treated with L-Carnosine since June of 2001. Furthermore, Chez reports no signs of adverse liver, blood, kidney, or central nervous system side effects.

Abstract

Double-Blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorder
By Michael G. Chez, M.D., Cathleen P. Buchanan, Ph.D., Jamie L. Komen, M.A., Marina Becker, R.N.
OBJECTIVE: L-Carnosine is an amino acid dipeptide that may enhance frontal lobe function. We therefore sought to investigate whether L-Carnosine supplementation for children with Autistic Spectrum Disorders (ASD) results in observable, objective changes in language and/or behavior in contrast to placebo.
DESIGN/METHODS: Thirty-one children (21 M, mean age= 7.45; range = 3.2-12.5 yrs) meeting inclusion criteria were enrolled in an 8 week blinded trial of either 400 mg BID powdered L-Carnosine or placebo. Children were assessed at a pediatric neurology clinic with the Childhood Autism Rating Scale (CARS), the Gilliam Autism Rating Scale (GARS), the Expressive and Receptive One-Word Picture Vocabulary tests (E/ROWPVT), and biweekly parental Clinical Global Impression of Change (CGI), at baseline and 8 week endpoint.
RESULTS: Children on placebo (n=17) did not show statistically significant changes on any of the outcome measures. After 8 weeks on L-Carnosine, children (n=14) showed statistically significant improvements on the GARS total score, GARS Behavior, Socialization, and Communication subscales, and the ROWPVT (all p’s<.05).EOWPVT and CARS showed trends in improvements, which were supported by parental CGI.
CONCLUSIONS: Oral supplementation with L-Carnosine resulted in demonstrable improvements in autistic behaviors as well as increases in language comprehension that reached statistical significance. Although the mechanism of action of the amino acid is not well understood, it is believed that it acts to modulate neurotransmission and affect metal ion transfer of zinc and copper in the entorhinal cortex. This may enhance neurological function or act in a neuroprotective fashion.
Source: https://nutritionreview.org/2013/04/lcarnosine-autism/

Limitless Energy by 2030 - China's HL-2M Tokamak

Could we have LIMITLESS energy in 13 years? Doughnut-shaped device to 'put fusion power into the grid' by 2030


  • Tokamak Energy's device uses magnets to heat plasma to 15 million°C
  • The firm claims that its spherical design is a 'fast route to fusion'
  • It is working on a nuclear reactor that it says will be built by 2025




In the race to end the world's reliance on fossil fuels, a fusion power firm has put forward the most ambitious timelines yet.
Tokamak Energy plans to start operating its fusion reactor this spring, and claims that its first commercial prototype will be built by 2025.
At a fraction of the size of other nuclear reactors, Tokamak's device uses a 'spherical tokamak', which the firm describes as the 'fast route to fusion.'
Scroll down for video 
The firm's reactor will use 'spherical tokamaks' – an experimental machine designed to harness the energy of fusion. Pictured is the magnetic coil structure of the ST40 with plasma (purple) inside. The magnetic coils make a trap for the hot plasma, keeping it away from the walls
The firm's reactor will use 'spherical tokamaks' – an experimental machine designed to harness the energy of fusion. Pictured is the magnetic coil structure of the ST40 with plasma (purple) inside. The magnetic coils make a trap for the hot plasma, keeping it away from the walls

WHAT IS A TOKAMAK? 

The tokamak is the most developed magnetic confinement system and is the basis for the design of fusion reactors.
Plasma is contained in a vacuum vessel, which is then heated by driving a current through it. 
A combination of two sets of magnetic coils creates a field in both vertical and horizontal directions, acting as a magnetic 'cage' to hold and shape the plasma.
The heating provided by the plasma current supplies a third of the 100 million°C temperature required to make fusion occur.
Additional plasma heating is provided when neutral hydrogen atoms are injected at high speed into the plasma, ionized and trapped by the magnetic field. As they are slowed down, they transfer their energy to the plasma and heat it. 
High-frequency currents are also induced in the plasma by external coils.
The frequencies are chosen to match regions where the energy absorption is very high.
In this way, large amounts of power may be transferred to the plasma.
The bold claims come from David Kingham, chief executive of Tokamak Energy, who was speaking at the International Energy Agency meeting last week.
The firm's reactor will use 'spherical tokamaks' – an experimental machine designed to harness the energy of fusion, unlike other firms who are using more 'conventional tokamaks'.
Mr Kingham said: 'By pursuing this route, fusion researchers around the world, including at Tokamak Energy, are developing new materials and technologies to help us get fusion power into the grid by 2030.'
Oxfordshire-based Tokamak Energy's technology revolves around high temperature superconducting (HTS) magnets, which allow for relatively low-power and small-size devices, but high performance.
In 2015, the world's first tokamak with HTS magnets – Tokamak Energy's second reactor – demonstrated 29 hours of continuous plasma, which was a world record.
Mr Kingham said: 'The plasma is where the fusion reaction takes place, and its stability is crucial.'
The firm is now working on its next ST40 reactor which it claims will produce plasma temperatures of 15 million°C – hotter than the centre of the sun.


Read more: http://www.dailymail.co.uk/sciencetech/article-4175442/First-commercial-fusion-reactor-built-2025.html#ixzz4XaOpSysP
Follow us: @MailOnline on Twitter | DailyMail on Facebook


Mr Kingham said: 'The ST40 is designed to achieve 100 million°C and get within a factor of ten of energy break-even conditions.
'To get even closer to break-even point, the plasma density, temperature and confinement time then need to be fine-tuned. 
'The next step is to build a reactor that takes this knowledge and uses it to demonstrate first electricity from fusion by 2025. 
The technology revolves around high temperature superconducting (HTS) magnets, which allow for relatively low-power and small-size devices, but high performance
The technology revolves around high temperature superconducting (HTS) magnets, which allow for relatively low-power and small-size devices, but high performance
'This will then form the basis of a power plant module that will deliver electricity into the grid by 2030.'
In an interview with World Nuclear News, Mr Kingham said that the ST40 is due to be completed this spring. 
But Tokamak Energy faces some strict competition from Tri Alpha Energy, a rival firm that has already developed a machine that can hold hot plasma steady at 18 million°F (10 million°C) for 11.5 milliseconds.
The ST40 is designed to achieve 100 million°C and get within a factor of ten of energy break-even conditions (artist's impression)
The ST40 is designed to achieve 100 million°C and get within a factor of ten of energy break-even conditions (artist's impression)
High-frequency currents are also induced in the plasma by external coils
The frequencies are chosen to match regions where the energy absorption is very high
A combination of two sets of magnetic coils creates a field in both vertical and horizontal directions, acting as a magnetic 'cage' to hold and shape the plasma
The firm recently received $500 million (£405 million) to created a commercial fusion reactor, that it claims will be ready be 2027. 
The particular type of fusion power Tri Alpha is working on is based on heating hydrogen atoms to temperatures of 5.4 billion°F (3 billion°C) - which is hotter than the surface of the sun.
The heat creates plasma that has a mixture of electrons and ions. 
When ions in a plasma collide, they fuse together to form new atoms and release huge amounts of energy.
It's a relatively simple concept, but the trick is in heating the gas to such a high temperature. Currently no known material can hold this heat.
Tri Alpha Energy has already developed a machine that can hold hot plasma steady at 18 million°F (10 million°C) for 11.5 milliseconds
Tri Alpha Energy has already developed a machine that can hold hot plasma steady at 18 million°F (10 million°C) for 11.5 milliseconds
Over the years, scientists have come up with two main methods to overcome this; cause an implosion that occurs rapidly, or use a magnetic field.
Tri Alpha Energy is using the latter option, but says it has made its breakthrough with an unusual reactor design - a long, tube that collides pairs of plasma donuts to produce heat.
According to a detailed report in Science, the team has placed magnets around a cigar shaped configuration that allows for firing angled plasma beams at one another.
Tri Alpha Energy's reactor features an unusual design - a long, tube (pictured) that collides pairs of plasma doughnuts to produce heat
Tri Alpha Energy's reactor features an unusual design - a long, tube (pictured) that collides pairs of plasma doughnuts to produce heat
The plasma that forms from its hydrogen and boron sample is then stabilised with beams of high-energy particles.
'Until you learn to control and tame [the hot gas], it's never going to work. 
'In that regard, it's a big deal. They seem to have found a way to tame it,' Jaeyoung Park, head of the rival fusion start-up Energy/Matter Conversion Corporation in San Diego told Science.
Take a tour of the world's largest nuclear fusion experiment

Loaded: 0%
Progress: 0%
00:00
Previous
Play
Skip
Mute
Current Time0:00
/
Duration Time0:00
Fullscreen



Read more: http://www.dailymail.co.uk/sciencetech/article-4175442/First-commercial-fusion-reactor-built-2025.html#ixzz4XaOdV8Ev

Pope Francis Takes Control of the Knights of Malta

Personal note: The Knights of Malta is a powerful organization with many of its members holding top CEO positions, including stewards of the CIA - FBI - NASA, U.S. Presidents, queens, princes and kings......The Jesuits have taken full control of the Vatican and once an autonomous military order.


Pope Francis talks with Fra Matthew Festing, grand master of the Sovereign Military Order of Malta in 2016. Bob Brehl says there's more to the tension between the Vatican and Malta than meets the eye.
Pope Francis talks with Fra Matthew Festing, grand master of the Sovereign Military Order of Malta in 2016. Bob Brehl says there's more to the tension between the Vatican and Malta than meets the eye.CNS photo/Maria Grazia Picciarella, pool

Comment: More to Malta Affair than meets the eye

BY  
  • February 2, 2017
One must wonder whether the rather bizarre clash between the Vatican and the Knights of Malta — a Catholic humanitarian organization with diplomatic ties to more than 100 countries — is really about distributing condoms as part of an aid project.Or are the condoms a red herring and the real story is part of a Machiavellian plan by conservative Catholic leaders — one American cardinal, in particular — to undermine Pope Francis and his reforms?
No one from the Vatican or the order is talking — officially — but many things point to the latter. One thing is abundantly clear: This smiling, inclusive and pastoral Pope is not afraid to use an iron fist when defiance trumps dialogue.
The “Malta Affair” has been dubbed a soap opera by European media. With its many twists and turns — even a link to the failed assassination of Adolf Hitler in 1944 — it almost reads like a John le Carré or Len Deighton novel.
It started in early December when Albrecht von Boeselager, second in command of the Knights of Malta, was fired by his then-boss Matthew Festing, the British Grand Master of the ancient Catholic order, in a row over condoms being distributed to combat HIV in Myanmar (formerly Burma). Von Boeselager, whose father Philipp was part of the famous failed Hitler assassination plot called Operation Valkyrie, claimed he was wrongly dismissed and appealed to the Vatican.
The sacking apparently struck a nerve with the Vatican, partly because it was unexpected, but also because Raymond Burke, an American cardinal who has clashed publicly with Pope Francis on social issues, is the Church’s envoy to the order. Tongues began to wag over his role in the firing.
For context, the pontiff demoted Burke from a top Vatican job in 2014 with no official explanation and assigned him to be the “patron” of the Order of Malta.
Such patron positions are typically given to older cardinals after they retire at 75, but Burke is only 68.
Burke has emerged as an outspoken critic of the Pope and a supporter of U.S. President Donald Trump for his positions on abortion and immigration, as The Register has reported recently. In November, Burke also led a rare public papal challenge with three other cardinals and accused the pontiff of sowing confusion on various issues such as communion for the divorced.
Meanwhile, before Christmas the Pope set up a special commission to investigate von Boeselager’s firing. Festing, the Grand Master elected for life, resisted the probe and refused to cooperate on the grounds the order is sovereign and independent of the Church.
He even issued a series of increasingly defiant public statements. In one, he called the investigating papal commission “legally irrelevant.” This clearly irritated Pope Francis and he continued to press. Vatican watchers claimed the real reason for von Boeselager’s firing was that Festing and Burke viewed him as too progressive and too loyal to Francis.
In the end, Festing caved at the end of January, becoming the first Grand Master to resign since 1799. Von Boeselager has been reinstated to his former position, an interim Grand Master has been appointed until an election, and the charitable organization will be under the jurisdiction of a special papal delegate, who will be appointed by Francis.
And just after this unfolded, more information leaked out indicating acrimony between Burke and the pontiff. Reuters news agency reported that “the day after Festing handed his resignation to the Pope, Burke drove to the order’s headquarters from his apartment near the Vatican and sought to persuade Festing to withdraw his resignation, a source from the Vatican and one from the Knights said.”
If this is accurate, it shows deep strains of discontent and disloyalty within the Church. In the end, Pope Francis won the battle and sent a warning that there are consequences for open disloyalty. But at what price?
The Order of Malta was founded in 1048 to provide medical aid for pilgrims and Crusaders in the Holy Land. Over 1,000 years, it has grown into an organization that cares for the sick and the poor in around 120 countries, managing hospitals and health centres and working in war zones and regions hit by natural disasters. It has 13,000 members, 80,000 volunteers and 20,000 paid medical staff.
No doubt, in part due to this good work, the Order of Malta holds the status of a sovereign entity, issuing its own passports, stamps and license plates from its Rome headquarters. It also has observer status at the United Nations.
One can only hope this clash has not damaged its image so that it negatively impacts things like donations, membership and volunteers. Another question is just how deep and determined is the opposition to Pope Francis?
As John Allen, editor of Catholic news site Crux, told the Financial Times: “It will be taken as an index of Francis’ determination not to be cowed by his critics, and not just when it comes to the Knights of Malta. It also confirms what we’ve always known, which is that Francis has a stubborn streak. He may consult widely beforehand, but once he’s made a decision, there’s generally no turning back and no reconsideration.”
It will be interesting to see what news Burke, who remains the order’s patron, is tied to in the coming weeks and months.
(Brehl is a writer in Port Credit, Ont., and can be reached at bob@abc2.ca or @bbrehl on Twitter.)

Source: http://www.catholicregister.org/opinion/columnists/item/24232-comment-more-to-malta-affair-than-meets-the-eye